Toggle navigation
Home
Medical
EU Panel Backs New Drug for Infant Immunization of RSV
17-9-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
1972
What could be the first vaccine for infants to prevent illness caused by respiratory syncytial virus (RSV) has received a nod from the European Medicines Agency. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
UW Medicine researchers seek participants for Phase 3...
Durability of immune protection after booster...
Prenatal Dental Care Is Important For Mother and Infant Baby
What is NuCalm? The Drug-Free Alternative to Sedation...
A novel drug suppresses muscle inflammation and helps...
Study: Opioid drug tolerance develops from interplay of...
Interdisciplinary panel offers solutions to improve...
STAT+: Blueprint Medicines drug reduces mastocytosis...
Drug combo can produce stronger flu treatment, study finds
How New Federal Legislation Might Cut Your Drug Costs